Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling

Julian C. Braz(Cincinnati Children's Hospital Medical Center), Jeffery D. Molkentin(Cincinnati Children's Hospital Medical Center)
Journal of Clinical Investigation
May 15, 2003
Cited by 306


Related Papers